Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Angina Pectoris/MI
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Angina Pectoris/MI
    Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis - (JAMA)
    Invasive Treatment Appears Beneficial for Men and High-Risk Women With Certain Coronary Syndromes - (DGNews)
    Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents - (JAMA)
    New Guidance Available for Cardiologists Treating Myocardial Bridging - (DGNews)
    TopAbstracts in Angina Pectoris/MI 06/25/2008 - (DGNews)

    News archive

     Recent webcasts/CME - Angina Pectoris/MI
      Optimizing Antiplatelet Therapy in the ACS Patient: The Intersection of Acute Coronary Syndromes and Oral Antiplatelet Therapy
      Use of Direct Thrombin Inhibitors for Treating Non-St-Segment Elevation Acute Coronary Syndromes in Special Patient Groups: Women, Diabetics, the Elderly, and Chronic Renal Insufficiency
      CRUSADE: Contemporary Evaluation and Management of 200,000 High-Risk NSTE-ACS Patients
      Understanding Chronic Ischemic Heart Disease Today
      Risk Stratification in Patients with Chronic Myocardial Ischemia

      Webcasts/CME archive

       Recent cases - Angina Pectoris/MI
        Diagnostic Uncertainty of Takotusbo Cardiomyopathy Presenting as Acute Myocardial Infarction in a Woman with Cardiovascular Risk Factors Hijacked at Gunpoint: A Case Report
        The Role of Intravascular Ultrasound in the Management of Spontaneous Coronary Artery Dissection
        Unusual Cause of Exercise-Induced Ventricular Fibrillation in a Well-Trained Adult Endurance Athlete: A Case Report
        Myocardial Ischemia in the Absence of Epicardial Coronary Artery Disease in Friedreich's Ataxia
        Double Rupture of Interventricular Septum and Free Wall of the Left Ventricle, as a Mechanical Complication of Acute Myocardial Infarction: A Case Report

        Cases archive
          




        my personal edition > angina pectoris/mi > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Cardioverter-Defibrillator Reduces Sudden Death Compared With Amiodarone

        A DGReview of :"Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction: Results of long-term follow-up"
        Journal of the American College of Cardiology (JACC)

        06/18/2002
        By Robert Short


        An implantable cardioverter-defibrillator produces better survival rates than does amiodarone therapy in sustained ventricular tachyarrhythmias after heart attack.

        This conclusion was the result of a study of 84 patients, carried out by Dr J Schläpfer and colleagues at the Division of Cardiology, University Hospital (CHUV), Lausanne, Switzerland. The patients who had experienced myocardial infarction had a mean left ventricular ejection fraction of about 36 percent.

        Roughly half the patients were found to be responders to amiodarone therapy. The non responders were eventually treated with an implantable cardioverter-defibrillator.

        The investigators found that during a mean follow-up period of 63 months, the sudden cardiac death rate and total mortality rate were significantly higher in the amiodarone-treated patients.

        Dr Schläpfer concluded, "The long-term survival of patients with sustained ventricular tachyarrhythmias after myocardial infarction, with depressed left-ventricular function, is significantly better with an implantable cardioverter-defibrillator than with amiodarone therapy."

        This finding on long-term survival was true even when patients were stratified according to the results of electrophysiological studies at base line and after a loading dose of amiodarone. "These patients should benefit from early implantable cardioverter-defibrillator, and previous amiodarone treatment seems to have no additional value."
        Journal of the American College of Cardiology 2002;39(11):1813-1819. "Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction: Results of long-term follow-up"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send